Skip to main content
Year archive

AstraZeneca PLC — 2019 filings

All 250 regulatory filings released by AstraZeneca PLC (AZN) in 2019, sourced directly from the official regulator.

250 Filings
2019 Period
2019 filings (250)
Filing Released Lang
Annual Financial Report 2019
Annual Report FY 2019
2019-12-31 English
LYNPARZAAPPROVED IN THE US AS A 1ST-LINE MAINTENANCE TREATMENT OF GERMLINE BRCA-
Foreign Filer Report
2019-12-30 English
US FDA approved Lynparza for pancreatic cancer
Regulatory Filings
2019-12-30 English
ASTRAZENECA'S TRIPLE-COMBINATION THERAPY APPROVED IN CHINA FOR PATIENTS WITH COP
Foreign Filer Report
2019-12-23 English
ENHERTU (TRASTUZUMAB DERUXTECAN) APPROVED IN THE US FOR HER2-POSITIVE UNRESECTAB
Foreign Filer Report
2019-12-23 English
Triple-combination approved in China for COPD
Regulatory Filings
2019-12-23 English
Enhertu (trastuzumab deruxtecan) approved in US
Regulatory Filings
2019-12-23 English
ASTRAZENECA DIVESTS RIGHTS TO ARIMIDEX AND CASODEX IN EUROPE AND CERTAIN ADDITIO
Foreign Filer Report
2019-12-20 English
AstraZeneca divests rights to Arimidex and Casodex
Regulatory Filings
2019-12-20 English
FDA PANEL BACKS LYNPARZA USE FOR PANCREATIC CANCER
Foreign Filer Report
2019-12-17 English
FDA panel backs Lynparza use for pancreatic cancer
Legal Proceedings Report
2019-12-17 English
SEROQUEL RIGHTS AGREEMENT COMPLETE: EUROPE, RUSSIA
Foreign Filer Report
2019-12-16 English
Seroquel rights agreement complete: Europe, Russia
Regulatory Filings
2019-12-16 English
IMFINZI APPROVED IN CHINA FOR THE TREATMENT OF UNRESECTABLE, STAGE III NON-SMALL
Foreign Filer Report
2019-12-12 English
Imfinzi approved in China for Stage III NSCLC
Regulatory Filings
2019-12-12 English
TRASTUZUMAB DERUXTECAN ACHIEVED A TUMOUR RESPONSE RATE OF 60.9% IN PIVOTAL PHASE
Foreign Filer Report
2019-12-11 English
Trastuzumab deruxtecan achieves ORR of 60.9%
Earnings Release FY 2019
2019-12-11 English
LYNPARZA APPROVED IN CHINA AS A 1ST-LINE MAINTENANCE THERAPY IN BRCA-MUTATED ADV
Foreign Filer Report
2019-12-05 English
Lynparza approved in China for 1L BRCAm ovarian
Regulatory Filings
2019-12-05 English
ASTRAZENECA DIVESTS RIGHTS TO SEROQUEL AND SEROQUEL XR IN THE US AND CANADA
Foreign Filer Report
2019-12-03 English
AstraZeneca divests Seroquel rights: US and Canada
Regulatory Filings
2019-12-03 English
BLOCK LISTING INTERIM REVIEW
Foreign Filer Report
2019-12-02 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-12-02 English
Block listing Interim Review
Regulatory Filings
2019-12-02 English
Total Voting Rights
Regulatory Filings
2019-12-02 English
IMFINZI GRANTED FDA PRIORITY REVIEW FOR THE TREATMENT OF PATIENTS WITH EXTENSIVE
Foreign Filer Report
2019-11-29 English
Imfinzi granted FDA Priority Review for SCLC
Earnings Release Q4 2019
2019-11-29 English
CALQUENCE APPROVED IN THE US FOR ADULT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEM
Foreign Filer Report
2019-11-21 English
Calquence approved in CLL in the US
Regulatory Filings
2019-11-21 English
QTRILMET APPROVED IN THE EU FOR TREATMENT OF T2D
Foreign Filer Report
2019-11-15 English
Qtrilmet approved in the EU for treatment of T2D
Regulatory Filings
2019-11-15 English
FDA ACCEPTS REGULATORY SUBMISSION FOR SELUMETINIB
Foreign Filer Report
2019-11-14 English
FDA accepts regulatory submission for selumetinib
Regulatory Filings
2019-11-14 English
ANIFROLUMAB DEMONSTRATED SUPERIORITY ACROSS MULTIPLE EFFICACY ENDPOINTS IN PATIE
Foreign Filer Report
2019-11-12 English
ROXADUSTAT PHASE III PROGRAMME POOLED ANALYSES SHOWED POSITIVE EFFICACY AND NO I
Foreign Filer Report
2019-11-12 English
Anifrolumab demonstrated superiority in TULIP 2
Earnings Release FY 2019
2019-11-12 English
Roxadustat pooled analyses: no increased CV risk
Regulatory Filings
2019-11-11 English
ROXADUSTAT SIGNIFICANTLY INCREASED HAEMOGLOBIN LEVELS FOR CHRONIC KIDNEY DISEASE
Foreign Filer Report
2019-11-08 English
FORM F-3ASR
Regulatory Filings
2019-11-08 English
Roxadustat significantly increased haemoglobin
Regulatory Filings
2019-11-08 English
CALQUENCE DATA TO SHOW IMPROVED PROGRESSION-FREE SURVIVAL IN PHASE III FRONT-LIN
Foreign Filer Report
2019-11-06 English
Calquence data to show improved progression-free
Earnings Release FY 2019
2019-11-06 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-11-01 English
Total Voting Rights
Regulatory Filings
2019-11-01 English
ASTRAZENECA DIVESTS RIGHTS TO SEROQUEL AND SEROQUEL XR IN EUROPE AND RUSSIA
Foreign Filer Report
2019-10-30 English
AstraZeneca divests rights to Seroquel and
M&A Activity
2019-10-30 English
IMFINZI AND IMFINZI PLUS TREMELIMUMAB DELAYED
Foreign Filer Report
2019-10-28 English
Imfinzi and Imfinzi plus tremelimumab delayed
Legal Proceedings Report
2019-10-28 English
SC 13D
Major Shareholding Notification
2019-10-25 English
ASTRAZENECA YEAR-TO-DATE AND Q3 2019 RESULTS
Foreign Filer Report
2019-10-24 English
AstraZeneca year-to-date and Q3 2019 results
Earnings Release 9M 2019
2019-10-24 English
FARXIGA APPROVED IN THE US TO REDUCE THE RISK OF HOSPITALISATION FOR HEART FAILU
Foreign Filer Report
2019-10-21 English
Farxiga approved in the US to reduce the risk of
Regulatory Filings
2019-10-21 English
TRASTUZUMAB DERUXTECAN GRANTED FDA PRIORITY REVIEW FOR TREATMENT OF PATIENTS WIT
Foreign Filer Report
2019-10-17 English
Trastuzumab deruxtecan granted FDA Priority Review
Regulatory Filings
2019-10-17 English
FORM 4 SUBMISSION
Director's Dealing
2019-10-09 English
FORM 3/A SUBMISSION
Director's Dealing
2019-10-09 English
HOLDING(S) IN COMPANY
Foreign Filer Report
2019-10-04 English
HOLDING(S) IN COMPANY
Foreign Filer Report
2019-10-04 English
Holding(s) in Company
Major Shareholding Notification
2019-10-04 English
Holding(s) in Company
Major Shareholding Notification
2019-10-04 English
FASENRA APPROVED IN THE US FOR SELF-ADMINISTRATION
Foreign Filer Report
2019-10-04 English
Fasenra approved in the US for self-administration
Environmental & Social Information
2019-10-04 English
DIRECTOR DECLARATION
Foreign Filer Report
2019-10-03 English
Director Declaration
Board/Management Information
2019-10-03 English
FORM 3 SUBMISSION
Director's Dealing
2019-10-03 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-10-01 English
Total Voting Rights
Regulatory Filings
2019-10-01 English
ASTRAZENECA DIVESTS RIGHTS FOR LOSEC TO CHEPLAPHAR
Foreign Filer Report
2019-10-01 English
UPDATE ON US REGULATORY REVIEW OF PT010 IN COPD
Foreign Filer Report
2019-10-01 English
AstraZeneca divests rights for Losec to Cheplaphar
M&A Activity
2019-10-01 English
Update on US regulatory review of PT010 in COPD
Regulatory Filings
2019-10-01 English
LYNPARZA MORE THAN DOUBLED THE TIME WITHOUT RADIOGRAPHIC DISEASE PROGRESSION IN
Foreign Filer Report
2019-09-30 English
Lynparza more than doubled the time without
Earnings Release FY 2019
2019-09-30 English
LYNPARZA IMPROVED THE TIME WOMEN LIVED WITHOUT DISEASE PROGRESSION TO 22 MONTHS
Foreign Filer Report
2019-09-30 English
TAGRISSO IS THE ONLY 1ST-LINE TREATMENT FOR EGFR-MUTATED NON-SMALL CELL LUNG CAN
Foreign Filer Report
2019-09-30 English
Tagrisso is the only 1st-line treatment for EGFR-
Regulatory Filings
2019-09-30 English
Lynparza improved the time women lived without
Legal Proceedings Report
2019-09-30 English
QTRILMET RECOMMENDED FOR APPROVAL IN EU BY CHMP
Foreign Filer Report
2019-09-23 English
Qtrilmet recommended for approval in EU by CHMP
Regulatory Filings
2019-09-23 English
Delisting Announcement 2019
Delisting Announcement
2019-09-18 English
ASTRAZENECA AMENDS COLLABORATION WITH IRONWOOD FOR LINZESS IN CHINA
Foreign Filer Report
2019-09-18 English
AstraZeneca amends collaboration with Ironwood
M&A Activity
2019-09-18 English
IMFINZI IS FIRST IMMUNOTHERAPY TO SHOW BOTH SIGNIFICANT SURVIVAL BENEFIT AND IMP
Foreign Filer Report
2019-09-09 English
TAGRISSO APPROVED IN CHINA AS A 1ST-LINE TREATMENT FOR EGFR-MUTATED NON-SMALL CE
Foreign Filer Report
2019-09-04 English
Tagrisso approved in China as a 1st-line treatment
Regulatory Filings
2019-09-04 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-09-03 English
DETAILED RESULTS FROM PHASE III DAPA-HF TRIAL SHOWED FARXIGA SIGNIFICANTLY REDUC
Foreign Filer Report
2019-09-03 English
BRILINTA REDUCED THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ART
Foreign Filer Report
2019-09-03 English
Total Voting Rights
Regulatory Filings
2019-09-02 English
Brilinta reduced the risk of cardiovascular events
Legal Proceedings Report
2019-09-02 English
Detailed results from Phase III DAPA-HF trial
Regulatory Filings
2019-09-02 English
ANIFROLUMAB PHASE III TRIAL MEETS PRIMARY ENDPOINT IN SYSTEMIC LUPUS ERYTHEMATOS
Foreign Filer Report
2019-08-29 English
Anifrolumab Phase III trial meets primary endpoint
Regulatory Filings
2019-08-29 English
BREZTRI AEROSPHERE PHASE III ETHOS TRIAL MET ITS PRIMARY ENDPOINT IN CHRONIC OBS
Foreign Filer Report
2019-08-28 English
FASENRA GRANTED US ORPHAN DRUG DESIGNATION FOR EOSINOPHILIC OESOPHAGITIS
Foreign Filer Report
2019-08-28 English
Fasenra granted US Orphan Drug Designation for
Regulatory Filings
2019-08-28 English
Breztri Aerosphere Phase III ETHOS trial met
Earnings Release FY 2019
2019-08-28 English
ROXADUSTAT APPROVED IN CHINA FOR THE TREATMENT OF ANAEMIA IN NON-DIALYSIS-DEPEND
Foreign Filer Report
2019-08-22 English
ASTRAZENECA AGREES TO BUY US FDA PRIORITY REVIEW
Foreign Filer Report
2019-08-22 English
Roxadustat approved in China for the treatment of
Regulatory Filings
2019-08-22 English
AstraZeneca agrees to buy US FDA Priority Review
M&A Activity
2019-08-22 English
UPDATE ON THE PHASE III NEPTUNE TRIAL
Foreign Filer Report
2019-08-21 English
Update on the Phase III NEPTUNE trial
Regulatory Filings
2019-08-21 English
FARXIGA MET PRIMARY ENDPOINT IN LANDMARK PHASE III
Foreign Filer Report
2019-08-20 English
Farxiga met primary endpoint in landmark Phase III
Regulatory Filings
2019-08-20 English
DIRECTORATE CHANGE
Foreign Filer Report
2019-08-19 English
Directorate Change
Board/Management Information
2019-08-19 English
CALQUENCE GRANTED US BREAKTHROUGH THERAPY DESIGNATION
Foreign Filer Report
2019-08-14 English
LYNPARZA PHASE III PAOLA-1 TRIAL MET PRIMARY ENDPOINT
Foreign Filer Report
2019-08-14 English
Lynparza Phase III PAOLA-1 trial met primary endpo
Regulatory Filings
2019-08-14 English
Calquence granted US Breakthrough Therapy Designat
Regulatory Filings
2019-08-14 English
TAGRISSO SIGNIFICANTLY IMPROVES OVERALL SURVIVAL
Foreign Filer Report
2019-08-09 English
Amendment: Tagrisso significantly improves overall
Legal Proceedings Report
2019-08-09 English
Tagrisso significantly improves overall survival
Regulatory Filings
2019-08-09 English
LYNPARZA PHASE III PROFOUND TRIAL IN HRR*
Foreign Filer Report
2019-08-07 English
Lynparza Phase III PROfound trial in HRR*
Regulatory Filings
2019-08-07 English
FORXIGA LABEL UPDATED IN THE EU IN TYPE-2 DIABETES
Foreign Filer Report
2019-08-05 English
Forxiga label updated in the EU in type-2 diabetes
Regulatory Filings
2019-08-05 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-08-01 English
Total Voting Rights
Regulatory Filings
2019-08-01 English
6-K
Foreign Filer Report
2019-07-25 English
AZN: H1 2019 Results
Earnings Release H1 2019
2019-07-25 English
Operational Improvements and New Euskaltel CEO
Regulatory Filings
2019-07-16 English
UPDATE ON US REGULATORY DECISION FOR FARXIGA
Foreign Filer Report
2019-07-15 English
Update on US regulatory decision for Farxiga
Legal Proceedings Report
2019-07-15 English
IMFINZI GRANTED US ORPHAN DRUG DESIGNATION FOR SMALL CELL LUNG CANCER
Foreign Filer Report
2019-07-12 English
Imfinzi granted US Orphan Drug Designation for
Regulatory Filings
2019-07-12 English
Update on Zegona's Strategy for Euskaltel
Board/Management Information
2019-07-11 English
FASENRA RECEIVES POSITIVE EU CHMP OPINION FOR SELF
Foreign Filer Report
2019-07-01 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-07-01 English
Total Voting Rights
Regulatory Filings
2019-07-01 English
FORXIGA RECEIVES POSITIVE EU CHMP OPINION FOR
Foreign Filer Report
2019-07-01 English
Regulatory Filings 2019
Regulatory Filings
2019-06-27 English
IMFINZI IMPROVES OVERALL SURVIVAL AT INTERIM
Foreign Filer Report
2019-06-27 English
BREZTRI AEROSPHERE (PT010) APPROVED IN JAPAN FOR PATIENTS WITH CHRONIC OBSTRUCTI
Foreign Filer Report
2019-06-19 English
LYNPARZA APPROVED IN JAPAN FOR 1ST-LINE MAINTENANCE THERAPY IN BRCA-MUTATED ADVA
Foreign Filer Report
2019-06-19 English
BEVESPI AEROSPHERE APPROVED BY THE JAPANESE MINISTRY OF HEALTH, LABOUR AND WELFA
Foreign Filer Report
2019-06-19 English
Breztri Aerosphere (PT010) approved in Japan for
Regulatory Filings
2019-06-19 English
Bevespi Aerosphere approved by the Japanese
Regulatory Filings
2019-06-19 English
Lynparza approved in Japan for 1st-line
Regulatory Filings
2019-06-19 English
LYNPARZA APPROVED IN THE EU FOR 1ST-LINE
Foreign Filer Report
2019-06-18 English
Lynparza approved in the EU for 1st-line
Legal Proceedings Report
2019-06-18 English
CALQUENCE SIGNIFICANTLY PROLONGED THE TIME PATIENT
Foreign Filer Report
2019-06-17 English
Calquence significantly prolonged the time patient
Legal Proceedings Report
2019-06-17 English
Publication of a Prospectus
Regulatory Filings
2019-06-12 English
PUBLICATION OF A PROSPECTUS
Foreign Filer Report
2019-06-12 English
Publication of Base Prospectus
Capital/Financing Update
2019-06-12 English
Result of AGM
AGM Information
2019-06-10 English
CALQUENCE PHASE III ELEVATE-TN TRIAL MET PRIMARY
Foreign Filer Report
2019-06-06 English
Calquence Phase III ELEVATE-TN trial met primary
Legal Proceedings Report
2019-06-06 English
UPDATE ON EUSKALTEL BOARD REPRESENTATION
Regulatory Filings
2019-06-05 English
BLOCK LISTING INTERIM REVIEW
Foreign Filer Report
2019-06-03 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-06-03 English
Total Voting Rights
Regulatory Filings
2019-06-03 English
Block listing Interim Review
Share Issue/Capital Change
2019-06-03 English
LYNPARZA NEARLY DOUBLED THE TIME PATIENTS LIVED WITHOUT DISEASE PROGRESSION FROM
Foreign Filer Report
2019-06-03 English
Lynparza nearly doubled time patients lived with
Earnings Release FY 2019
2019-06-03 English
Director/PDMR Shareholding
Director's Dealing
2019-05-10 English
POOLED ANALYSES OF THE ROXADUSTAT GLOBAL PHASE III
Foreign Filer Report
2019-05-10 English
Pooled analyses of the roxadustat global Phase III
Earnings Release FY 2019
2019-05-10 English
Director/PDMR Shareholding
Director's Dealing
2019-05-08 English
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2019-05-08 English
DIRECTOR DECLARATION
Foreign Filer Report
2019-05-08 English
Director Declaration
Board/Management Information
2019-05-08 English
TRASTUZUMAB DERUXTECAN DEMONSTRATED CLINICALLY
Foreign Filer Report
2019-05-08 English
CALQUENCE PHIII ASCEND TRIAL MET PRIMARY ENDPOINT
Foreign Filer Report
2019-05-07 English
QTERNMET XR APPROVED IN THE US FOR TYPE-2 DIABETES
Foreign Filer Report
2019-05-03 English
Qternmet XR approved in the US for type-2 diabetes
Regulatory Filings
2019-05-03 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-05-01 English
Total Voting Rights
Regulatory Filings
2019-05-01 English
Director/PDMR Shareholding
Director's Dealing
2019-05-01 English
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2019-05-01 English
LYNPARZA RECEIVES POSITIVE EU CHMP OPINION FOR 1ST
Foreign Filer Report
2019-04-29 English
Lynparza receives positive EU CHMP opinion for 1st
Legal Proceedings Report
2019-04-29 English
RESULT OF AGM
Foreign Filer Report
2019-04-26 English
Result of AGM
AGM Information
2019-04-26 English
AZN: Q1 2019 RESULTS
Foreign Filer Report
2019-04-26 English
AZN: Q1 2019 Results
Earnings Release Q1 2019
2019-04-26 English
Special Business Approved at AGM
AGM Information
2019-04-26 English
Notice of AGM
AGM Information
2019-04-25 English
Final Results
Annual Report FY 2018
2019-04-25 English
LYNPARZA APPROVED IN EU FOR THE TREATMENT OF GERMLINE BRCA-MUTATED HER2-NEGATIVE
Foreign Filer Report
2019-04-10 English
Hardman & Co Research: Global Pharmaceuticals: 2018 industry sales
Regulatory Filings
2019-04-09 English
Holding(s) in Company
Major Shareholding Notification
2019-04-04 English
Holding(s) in Company
Major Shareholding Notification
2019-04-04 English
HOLDING(S) IN COMPANY
Foreign Filer Report
2019-04-04 English
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2019-04-03 English
Director/PDMR Shareholding
Regulatory Filings
2019-04-03 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-04-02 English
Total Voting Rights
Regulatory Filings
2019-04-02 English
Astrazeneca
Regulatory Filings
2019-04-01 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-04-01 English
Total Voting Rights
Regulatory Filings
2019-04-01 English
SELUMETINIB GETS BREAKTHROUGH THERAPY DESIGNATION
Foreign Filer Report
2019-04-01 English
Selumetinib gets Breakthrough Therapy Designation
Regulatory Filings
2019-04-01 English
RESULTS OF PLACING
Foreign Filer Report
2019-03-29 English
Results of Placing
Regulatory Filings
2019-03-29 English
AZ AND DAIICHI SANKYO ENTER COLLABORATION IN NOVEL
Foreign Filer Report
2019-03-29 English
Proposed placing of new ordinary shares
Share Issue/Capital Change
2019-03-29 English
AZ and Daiichi Sankyo enter collaboration in novel
Share Issue/Capital Change
2019-03-29 English
FORXIGA APPROVED IN JAPAN FOR TYPE-1 DIABETES
Foreign Filer Report
2019-03-27 English
Forxiga approved in Japan for type-1 diabetes
Regulatory Filings
2019-03-27 English
FORXIGA APPROVED IN EUROPE FOR TYPE-1 DIABETES
Foreign Filer Report
2019-03-25 English
US FDA GRANTS SARACATINIB ODD FOR IPF
Foreign Filer Report
2019-03-18 English
US FDA grants saracatinib ODD for IPF
Legal Proceedings Report
2019-03-18 English
NOTICE OF AGM
Foreign Filer Report
2019-03-14 English
6-K
Foreign Filer Report
2019-03-14 English
Notice of AGM
Report Publication Announcement
2019-03-14 English
Proxy Form
Proxy Solicitation & Information Statement
2019-03-14 English
Chairman's Letter
AGM Information
2019-03-14 English
AGM Notice
AGM Information
2019-03-14 English
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2019-03-12 English
Director/PDMR Shareholding
Remuneration Information
2019-03-12 English
FILING OF FORM 20-F WITH SEC
Foreign Filer Report
2019-03-06 English
Filing of Form 20-F with SEC
Report Publication Announcement
2019-03-06 English
IRANNOTICE
Regulatory Filings
2019-03-05 English
20-F
Annual Report FY 2018
2019-03-05 English
ANNUAL FINANCIAL REPORT
Foreign Filer Report
2019-03-05 English
Annual Financial Report
Report Publication Announcement
2019-03-05 English
Holding(s) in Company
Major Shareholding Notification
2019-03-04 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-03-01 English
LYNPARZA RECEIVES POSITIVE EU CHMP OPINION
Foreign Filer Report
2019-03-01 English
Total Voting Rights
Regulatory Filings
2019-03-01 English
Lynparza receives positive EU CHMP opinion
Legal Proceedings Report
2019-03-01 English
LYNPARZA SIGNIFICANTLY DELAYED DISEASE PROGRESSION
Foreign Filer Report
2019-02-26 English
Lynparza significantly delayed disease progression
Earnings Release FY 2019
2019-02-26 English
BRILINTA'S PHIII THEMIS TRIAL MET PRIMARY ENDPOINT
Foreign Filer Report
2019-02-25 English
Brilinta's PhIII THEMIS trial met primary endpoint
Earnings Release FY 2019
2019-02-25 English
ASTRAZENECA FULL-YEAR AND Q4 2018 RESULTS
Foreign Filer Report
2019-02-14 English
AstraZeneca Full-Year and Q4 2018 Results
Earnings Release FY 2018
2019-02-14 English
SEC SCHEDULE 13G
Major Shareholding Notification
2019-02-12 English
US FDA GRANTS FASENRA ORPHAN DRUG DESIGNATION
Foreign Filer Report
2019-02-06 English
US FDA grants Fasenra Orphan Drug Designation
Regulatory Filings
2019-02-06 English
US FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION
Foreign Filer Report
2019-02-05 English
EMA GRANTS PRIME ELIGIBILITY FOR MEDI8897
Foreign Filer Report
2019-02-05 English
US FDA grants Breakthrough Therapy Designation
Regulatory Filings
2019-02-05 English
EMA grants PRIME eligibility for MEDI8897
Regulatory Filings
2019-02-05 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-04 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-02-01 English
Total Voting Rights
Regulatory Filings
2019-02-01 English
FORXIGA RECEIVES POSITIVE EU CHMP OPINION
Foreign Filer Report
2019-02-01 English
Forxiga receives positive EU CHMP opinion
Regulatory Filings
2019-02-01 English
SC 13G
Major Shareholding Notification
2019-01-30 English
COMPLETION OF DIVESTMENT OF US SYNAGIS RIGHTS
Foreign Filer Report
2019-01-25 English
Completion of divestment of US Synagis rights
Regulatory Filings
2019-01-25 English
ASTRAZENECA ANNOUNCES ORGANISATIONAL CHANGES
Foreign Filer Report
2019-01-07 English
AstraZeneca announces organisational changes
Board/Management Information
2019-01-07 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2019-01-02 English
Total Voting Rights
Regulatory Filings
2019-01-02 English